Table 2.
Glycated hemoglobin levels over the course of the study, by group
Group
|
N
|
Mean
|
SD
|
Range
|
Median
|
IQR
|
FMT (n = 15) | ||||||
Baseline | 11 | 6.75 | 1.09 | 5.60–8.90 | 6.30 | 6.10–7.60 |
6 wk | 11 | 6.65 | 1.09 | 5.60–9.10 | 6.10 | 6.00–7.60 |
6 mo | 11 | 6.95 | 1.19 | 5.40–9.50 | 6.50 | 6.20–7.70 |
1 yr | 11 | 7.34 | 1.85 | 5.60–11.50 | 6.70 | 5.80–8.30 |
Placebo (n = 13) | ||||||
Baseline | 11 | 6.99 | 1.99 | 4.80–12.50 | 6.60 | 6.00–7.50 |
6 wk | 11 | 6.75 | 1.38 | 5.00–10.20 | 6.30 | 6.00–7.40 |
6 mo | 11 | 6.97 | 1.98 | 4.90–12.20 | 6.40 | 5.90–7.20 |
1 yr | 11 | 7.29 | 2.56 | 4.90–13.80 | 6.30 | 5.90–8.10 |
IQR: Interquartile range; FMT: Fecal microbiota transplantation.